| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 6,052 | 6,052 | 0 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CORPORATE BOND | 483,957 | 487,063 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| GENSCRIPT BIOTECH CORP SHARES | 2,764,012 | 1,018,150 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| OTHER INVESTMENT | AT COST | 4,201,871 | 4,295,161 |
| Description | Amount |
|---|---|
| UNREALIZED LOSS ON PALANTIR TECHNOLOGIES INC SHARES | 739,736 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MORGAN STANLEY ACCT MISCELLANEOUS FEES | 23,167 | 23,167 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| 21,529 | 21,529 | 21,529 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL | 4,057 | 4,057 | 0 | |
| NJ FILING | 30 | 30 | 0 |